p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach.

Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul, Korea.
Journal of Korean Medical Science (Impact Factor: 1.25). 09/2002; 17(4):490-6. DOI: 10.3346/jkms.2002.17.4.490
Source: PubMed

ABSTRACT To investigate the potential implication of the subtype of intestinal metaplasia in the progression to the gastric carcinoma, we analyzed the mutations of the p53 gene and microsatellite instability (MSI) both in the complete type (type I) and in the sulphomucin-secreting incomplete type (type III) intestinal metaplasia located adjacent to the gastric carcinoma. p53 mutations were observed in 13.3% of type I, in 6.6% of type III intestinal metaplasia, and in 40% of gastric carcinoma. The difference between p53 mutations observed in type I and type III intestinal metaplasia was not statistically significant. No identical mutation of the p53 gene was found in the intestinal metaplasia and carcinoma specimens from the patients. There was no case of intestinal metaplasia showing MSI. In gastric carcinomas, MSI was observed in six cases (40%). The cases harboring BAT-26 instability did not have the mutation of the p53 gene. These data suggest that intestinal metaplasia adjacent to gastric carcinoma, irrespective of its subtype, do not have the genetic alterations as showing in their carcinoma tissues.

  • Source
    Revista medica de Chile 01/2003; 131(12). · 0.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Genetic instability and inflammation are closely intertwined processes. While the induction of genetic instability in the setting of inflammation is easy to conceptualize, the reverse occurs as well. It has been appreciated for some time now that colon cancers that arise in the setting of DNA mismatch repair (MMR) deficiencies have a significant lymphocyte infiltration, suggesting an inflammatory response. This characteristic is being used clinically by pathologists to identify the approximately 15% of human colon cancers that develop with microsatellite instability (MSI) rather than the more common chromosomal instability. Inactivating mutations or gene silencing of hMLH1 or hMSH2, which are essential for normal MMR, are frequently observed in these cancers and account for the vast majority of hereditary non-polyposis colorectal cancer (HNPCC, or Lynch syndrome I) (Ionov et al. 1993; Thibodeau et al. 1993; Fishel et al. 1993; Leach et al. 1993). How the induction of MSI leads to the increased inflammatory response remains unknown. What is better understood is how chronic inflammatory processes provoke genetic instabilities that lead to the development of cancer.
    12/2009: pages 351-397;
  • [Show abstract] [Hide abstract]
    ABSTRACT: It has been frequently shown that p53 alterations have an important role in the development of gastric cancers but there is no data on p53 alteration in gastric cancer and its precancerous lesions from Iran although this country experiences one of the highest gastric cancer incidence and mortality rates in the world. The purpose of this study was to do a comprehensive assessment of p53 alterations in the Iranian population of gastritis patients and to evaluate the association between p53 alterations, microsatellite status and clinicopathological aspects. After DNA extraction, PCR sequencing was done for exons 2-7. Also microsatellite status was evaluated using five microsatellite markers: NR-27, NR-21, NR-24, BAT-25 and BAT-26. The highest rate of alteration was seen in codons 72 (85.6%, SNP) and 248 (30.9%, mutation). Also, we found 2 new mutations in codons 9 and 146. In contrast with previous work, transition at the CpG codons was relatively rare. Nucleotide alterations were more prevalent in the Helicobacter pylori-positive group but not significantly. Neither nuclear staining for p53 protein nor microsatellite instability was seen in gastritis lesions. p53 alterations might contribute to the pathogenesis of gastritis and perhaps gastric cancer in Iran. However, the different spectrum seen here implies other mechanism(s) in gastritis and gastric cancer development in the Iranian population.
    Digestion 10/2010; 83(1-2):65-75. · 2.03 Impact Factor

Preview (2 Sources)

1 Download
Available from